Aminoglycosides Flashcards

1
Q

General Properties of Aminoglycosides

Main structure

Spectrum?

Toxic?

Solubility in water?

Protein binding?

which ones are cidal?

Metabolism?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of Aminoglycosides?

A
  • AGs interact at t-RNA binding site of 30s ribosomal particle causing mistranslation of m-RNA leading to NONsense proteins
  • Has a low log p so it needs to be transported
  • Incorporation of misfolded protein into cell membrane allows more antibiotic to enter
  • Cessation of protein biosynthesis
  • Membran leaks K+ leading to death
  • Secondary mechanism is oxidative stress–>Cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Kanamycin the prototypical structure for amino glycosides, using the structure what do you know about it?

A
  • Resistance happens quickly with AME enzymes because all of its functional groups are either hydroxyl or amine
  • Structurally related to Tobramycin and Amikacin
  • Used to be used in anti TB cocktails
  • Extensive modification by R-factor enzymes at the C3 and C6 site inactivating it (repeat)
  • Not used anymore
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Resistance to Aminoglycosides

4 in total

A
  1. Enzymatic modification of AG (over 120 different AG-modifying enzymes are known)
    1. N-acetylation [AAC = aminoglycoside acetyl transferases]
    2. O-phosphorylation [APH = aminoglycoside phosphotransferases]
    3. O-adenylation [ANT = aminoglycoside adenyltransferases]

Resistance by enzymatic modification is structurally dependent. The altered drugs interact with bacterial ribosomes more weakly than the parent drugs.

  1. Poor uptake (can be intrinsic)
  2. Efflux
  3. Ribosomal mutations leading to decreased sensitivity (seems to involve automethylation of certain RNA bases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AMEs Covalently Modify and Deactivate AGs

With an AME what happens?

What is the goal?

A
  • With an AME-
    • Inactivated drug –> Poor binding to ribosomes–> Increases the MIC–>Causes phenotypic resistance
  • The goal it to overcome the action of the AMEs
    • —> Then you retain high concentrations —>lowers MIC–> Overcome resistance
  • Analogs are doing just this (Tobra, Genta, Amakacin)- These incorporate structures that overcome the action of the resistance so you can maintain a higher concentration so the concentration need is much lower this has a direct effect on resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AMEs dictate spectrum of coverage

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Genes Encoding AMEs Found on Plasmids AND Chromosomes

Can spread in what ways through population?

Some bacteria are more prone to share?

And some are more prone to?

A
  • AME-based resistance can be spread vertically or horizontally through a population
  • Some bacteria are more prone to share genes vertically
  • Some bacteria are more prone to share genes horizontally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rationally Designed Analogs To Overcome Resistance

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tobramycin Sulfate

Used for what type of bacteria?

A

Gram negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Gentamicin Sulfate

Lacks what ?

A
  • Lacks the two functional OHs on the C3 and C6 making it have an even better spectrum for gram (+)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Amikacin?

What makes this so good?

A
  • In many cases can over come bacteria that are resistant to Tobramycin or Gentamycin because it contains a HABA group
  • So a bacteria can have a bunch of AMEs but it wont recognize the structure of the drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spectinomycin this one is different why?

A
  • Has a different main structure and is static all other aminoglycosides are cidal
  • Treats TB and STDs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Streptomycin

Used?

A

Used in cocktails but resistance is common

First drug to ever get a blind study in 1946

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Systemic therapy with AGs

Combinations of what?

What type of approach?

A
  • Systemic therapy often used in combination with B-lactams and Vancomycin
    • Synergistic aproach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gentamicin More Gram?

What does it cover?

A
  • Positive
  • Covers S. Aureus
  • Viridans, Streptococcus
  • Enterococcus spp
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tobramycin covers?

Amikacin reserved for?

A
  • Gram Negative
  • S- erratia
    P- seudomonas
    A- cinitobacter
    C- Citrobacter
    E- Enterobacter
  • Amikacin is reserved for infections resistant to gentamicin and tobramycin
17
Q

Clinical properties and uses

A
18
Q

Class toxicities of AGs

A
19
Q

How dosing of AGs can minimize toxicity

A
  • PEak/MIC
  • PAE drug is still very active so dosing the drug Qday instead of q8h gives the host cells time to pump drug out this reduces the total toxicity of the drug.
20
Q

Spectrum coverage for AGs

A